Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix:: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies

被引:260
作者
de Gonzalez, Amy Berrington [1 ]
Green, Jane [1 ]
机构
[1] Univ Oxford, Epidemiol Unit, Nuffield Dept Clin Med, Oxford OX3 7LF, England
基金
英国医学研究理事会;
关键词
cervical cancer; HPV; adenocarcinoma; squamous cell carcinoma;
D O I
10.1002/ijc.22357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Squamous cell carcinomas account for about 80% of cancers of the uterine cervix, and the majority of the remainder are adenocarcinomas. There is limited evidence on the extent to which these histological types share a common etiology. The International Collaboration of Epidemiological Studies of Cervical Cancer has brought together and combined individual data on 8,097 women with invasive squamous cell carcinoma, 1,374 women with invasive adenocarcinorna and 26,445 women without cervical cancer (controls) from 12 epidemiological studies. Compared to controls, the relative risk of each histological type of invasive cervical cancer was increased with increasing number of sexual partners, younger age at first intercourse, increasing parity, younger age at first fullterm pregnancy and increasing duration of oral contraceptive use. Current smoking was associated with a significantly increased risk of squamous cell carcinoma (RR = 1.50, 95% CI: 1.35-1.66) but not of adenocarcinoma (RR = 0.86 (0.70-1.05)), and the difference between the two histological types was statistically significant (case-case comparison p < 0.001). A history of screening (assessed as having had at least one previous nondiagnostic cervical smear) was associated with a reduced risk of both histological types, but the reduction was significantly greater for squamous cell carcinoma than for adenocarcinoma (RR = 0.46 (0.42-0.50) and 0.68 (0.56-0.82), respectively; case-case comparison, p = 0.002). A positive test for cervical high-risk HPV-DNA was a strong risk factor for each histological type, with 74% of squamous cell carcinomas and 78% of adenocarcinomas testing positive for HPV types 16 or 18. Squamous cell and adenocarcinoma of the cervix share most risk factors, with the exception of smoking. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 40 条
  • [1] Cervical carcinoma and reproductive factors:: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
    Appleby, P.
    Beral, V.
    de Gonzalez, A. Berrington
    Colin, D.
    Franceschi, S.
    Green, J.
    La Vecchia, C.
    Peto, J.
    Plummer, M.
    Randi, G.
    Sweetland, S.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) : 1108 - 1124
  • [2] Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
  • [3] BERRY G, 1993, INT J CANCER, V55, P228
  • [4] LONG-TERM USE OF ORAL-CONTRACEPTIVES AND RISK OF INVASIVE CERVICAL-CANCER
    BRINTON, LA
    HUGGINS, GR
    LEHMAN, HF
    MALLIN, K
    SAVITZ, DA
    TRAPIDO, E
    ROSENTHAL, J
    HOOVER, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (03) : 339 - 344
  • [5] Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
    Castellsagué, X
    Díaz, M
    de Sanjosé, S
    Muñoz, N
    Herrero, R
    Franceschi, S
    Peeling, RW
    Ashley, R
    Smith, JS
    Snijders, PJF
    Meijer, CJLM
    Bosch, FX
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05): : 303 - 315
  • [6] Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt
  • [7] 546::AID-IJC9&gt
  • [8] 3.0.CO
  • [9] 2-T
  • [10] Risk factors for cervical cancer in Thailand:: A case-control study
    Chichareon, S
    Herrero, R
    Muñoz, N
    Bosch, FX
    Jacobs, MV
    Deacon, J
    Santamaria, M
    Chongsuvivatwong, V
    Meijer, CJLM
    Walboomers, JMM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) : 50 - 57